Stocks · Health care · Pharmaceutical Preparations

Lyell Immunopharma, Inc.

LYEL Clue Score29
United States Fiscal year ends December CIK 0001806952 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Innovative Cellular Therapeutics Holdings Ltd
17 Jul 2026
10% owner
Sold on a plan
10
$13.70
$137.00
Innovative Cellular Therapeutics Holdings Ltd
16 Jul 2026
10% owner
Sold on a plan
10
$13.73
$137.30

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 27
Transactions with no price 0
Shares from compensation/vesting 261,750
History held since 23 Jun 2021